# Protalix BioTherapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2020

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 10-K/A
- Filed: 2021-04-30
- Accepted by EDGAR: Apr 30, 2021, 06:44 ET
- Period: 2020-12-31
- Accession: 0001558370-21-005321
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000155837021005321/plx-20201231x10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000155837021005321/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000155837021005321/plx-20201231x10ka.htm

Filed Apr 30, 2021.
Source: SEC EDGAR, the filing index for accession 0001558370-21-005321. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
